Skip to content

Reducing Recurrence of Symptomatic Atrial Fibrillation After Catheter Ablation by App-based Mental Training

To Reduce Recurrence of Symptomatic Atrial Fibrillation and Improve Quality of Life After Catheter Ablation for Atrial Fibrillation by App-based Mental Training (Mental AF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04067427
Acronym
Mental-AF
Enrollment
183
Registered
2019-08-26
Start date
2019-08-16
Completion date
2022-12-30
Last updated
2023-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Meditation

Brief summary

Atrial fibrillation (AF) is one of the most common heart rhythm disorders and it is associated with a variety of symptoms leading to a considerable deterioration in quality of life. The Mental-AF trial is intended to inquire if an app-based mental training can reduce the occurrence of symptomatic AF episodes within the blanking period, i.e. the first three months after catheter ablation for AF.

Detailed description

To explore the potential of a daily app-based mindfulness mental training in improving AF symptoms, assessed by self-reported outcome measures, i.e. the AF 6 questionnaire, AF Effect on QualiTy of Life (AFEQT) and Patient Reported Outcome Measurement Information System (PROMIS) Global Health questionnaires, as well as in reducing AF burden in 7-day-Holter, within the first 12 weeks following AF ablation.

Interventions

App-based mental training

Sponsors

Heart Center Leipzig - University Hospital
CollaboratorOTHER
Helios Health Institute GmbH
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

* All patients undergoing AF ablation with symptomatic paroxysmal or chronic atrial fibrillation (EHRA II-IV) * Availability of smart phone with the capability to run android 5 or iOS 9 or newer versions * Capability to use mobile phone applications * Internet access * Consent to study participation

Exclusion criteria

* Patients \< 18 years of age * Unavailability of smart phone running at least Android 5 or iOS 9 * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Atrial Fibrillation (AF) 6 questionnaire score12 weeks, assessed weeklyAtrial fibrillation specific symptomatic outcome defined by AF 6 sum scores during the first 12 weeks following AF ablation, based on a 10-point Likert scale, ranging from 0 (no symptoms) to 10 (severe symptoms), sum scores ranging from 0 to 60.

Secondary

MeasureTime frameDescription
Atrial Fibrillation Effect on QualiTy of Life (AFEQT) scoreFollow up (3 months)Effects of AF on quality of Life, assessed by a 20-item questionnaire with 4 conceptual domains (daily Activities, treatment concern, symptoms and treatment satisfaction) on a 7-point Likert scale, responses ranging from 1 (no symptoms/limitations) to 7 (most severe limitations/symptoms), higher scores indicating better health status, the raw scores can be transformed to a 0 to 100 scale adjusting for missing data
Patient-Reported Outcome Measurement Information System (PROMIS) Global Health 10 scoreFollow up (3 months)PROMIS Global Health questionnaire for the assessment of physical and mental health domains by 10 items using a 5-point Likert scale, ranging from (5) excellent to (1) poor. Higher scores indicate a healthier patient.
Atrial fibrillation burdenFollow up (3 months)Time in AF as assessed in 7-day-Holter
Heart RateFollow up (3 months)Heart Rate during blood pressure measurement
Blood pressureFollow up (3 months)Office blood pressure measurement of diastolic and systolic blood pressure

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026